- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04048772
CALM IVF (oprettelse af tilknytninger, læring og mindfulness for in vitro fertiliseringspatienter)
Oprettelse af tilknytninger, læring og mindfulness for in vitro fertiliseringspatienter
The investigators have designed a psychoeducational group curriculum specifically for new in vitro fertilization (IVF) patients (both male and female) to improve their treatment knowledge, to allow them to engage more in their care, to offer a support network, to improve satisfaction, and to provide them with tools to help reduce their stress and anxiety while undergoing the IVF process. The investigators plan to have four to eight infertility patients and their partners participate in a group at a time, for which they will attend three 1-1.5 hour interactive sessions that are scheduled throughout their first IVF cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. They will do several surveys before and after the intervention for comparison, including assessment of quality of life, depression, anxiety, resilience, and a knowledge assessment. The investigators will also track the patients to see if they pursue additional treatment in the instance of a negative pregnancy test compared to patients undergoing the standard treatment. The investigators plan to recruit a control group that receives the standard of care treatment here at the University of Iowa.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Patients and their partners (if present and consenting) will be randomized in a 2:1 fashion to two different treatment arms: A) standard of care in vitro fertilization (IVF) at the investigational institution as well as participating in an additional psychoeducational group or B) standard of care IVF at the investigational institution. The intervention group will consist of three additional evening visits for 1-1.5 hours per session. The sessions will include an interactive educational component addressing usual questions and concerns of IVF patients, such as reviewing common IVF myths, and also more information regarding treatment and technologies. Each session will also include teaching of coping strategies (such as awaiting the pregnancy test, how to cope with insensitive remarks from friends and family) as well as relaxation exercises, such as progressive muscle relaxation and deep breathing.
The patients will be consented at their new IVF visit and will take their initial assessments (FertiQoL, GAD-7, PHQ-9, the Connor-Davidson Resilience Scale, and a knowledge assessment) within 24 hours of the new visit. The patients will be assigned into groups based on when they are going through their IVF stimulations, so they will have similar experiences at similar times. Patients will take their final assessments on the third day after egg retrieval, regardless of group assignment.
When partners are present and consent to the study, they will be treated as a dyad with the patient undergoing oocyte retrieval. Some patients go through treatment alone (i.e. single adults desiring pregnancy) and therefore may not have a partner available to participate. Partners level of involvement in a cycle may very, as may their desire to participate in a psychosocial intervention. As patients and their partners make joint decisions throughout their IVF cycle and the cycle itself has a single outcome, we enrolled partners as dyads with patients when partners were present, but did not require a partner to enroll a patient.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater, 52242
- University of Iowa Hospitals and Clinics
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- All patients starting their first in vitro fertilization cycle at the University of Iowa Hospitals and Clinics
Exclusion Criteria:
- Patients who have already undergone in vitro fertilization treatment at any institution
- Non-English speakers
- Fertility preservation patients
- Patients using donor oocytes, embryos, or sperm
- Patients taking psychotropic medications for depression or anxiety that have had a dosing adjustment within 3 months of study enrollment
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Intervention
Standard of care in vitro fertilization patients randomized to the psychoeducational group intervention. |
The intervention will be three 1-1.5 hour interactive sessions that are scheduled throughout the participant's first in vitro fertilization cycle. These sessions will provide additional time for discussion about treatment with providers, learning opportunities on topics of interest to fertility patients, and stress reduction techniques. |
|
Andet: Control
Standard of care in vitro fertilization patients at our institution. |
Patients will receive the standard of care IVF treatment at the University of Iowa. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in female fertility patient quality of life score during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in female GAD-7 score during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female PHQ-9 score during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female Connor-Davidson Resilience Scale during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in female knowledge assessment during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
|
Likelihood of continued IVF treatment in the instance of a negative pregnancy test
Tidsramme: Three months after embryo transfer
|
Patients who are not pregnant after embryo transfer will be followed for three months to assess likelihood to return for additional treatment after negative embryo transfer outcome. |
Three months after embryo transfer
|
|
Change in male fertility patient quality of life score during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
FertiQoL International (Fertility Quality of Life Questionnaire 2008), scored scale from 0-100, with higher values indicating a higher quality of life and low scores indicating a lower quality of life. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male GAD-7 score during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Generalized Anxiety Disorder 7-item scale, with higher scores indicating higher likelihood of an anxiety disorder and lower scores indicating less likelihood of an anxiety disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male PHQ-9 score during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Patient Health Questionnaire, with higher score indicating increased likelihood of a depressive disorder and lower scores indicating less likelihood of a depressive disorder. |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male Connor-Davidson Resilience Scale during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Connor-Davidson Resilience Scale, with higher scores indicating greater resilience, and lower scores indicating lower resilience |
From enrollment to 2-4 days after oocyte retrieval
|
|
Change in male knowledge assessment during IVF treatment cycle
Tidsramme: From enrollment to 2-4 days after oocyte retrieval
|
Assessment of knowledge regarding IVF treatment, with higher scores indicating a greater knowledge of IVF treatment, and lower scores indicating less knowledge regarding IVF treatment |
From enrollment to 2-4 days after oocyte retrieval
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Rachel M Whynott, MD, University of Iowa
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 201906788
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .